<?xml version="1.0" encoding="UTF-8"?>
<p>Drug repurposing screens have emerged as an attractive strategy to accelerate new drug discovery and development. This strategy offers various advantages over 
 <italic>de novo</italic> drug discovery featured with key benefits including reduced time, cost, and risk as well as the unique means for safer and more effective drugs to be accessed by patients.
 <sup>
  <xref ref-type="bibr" rid="ref8">8</xref>,
  <xref ref-type="bibr" rid="ref9">9</xref>
 </sup> Niclosamide is an FDA-approved anthelminthic drug that has been widely used in humans to treat tapeworm infections for several decades and is currently listed on the World Health Organization’s list of essential medicines.
 <sup>
  <xref ref-type="bibr" rid="ref10">10</xref>,
  <xref ref-type="bibr" rid="ref11">11</xref>
 </sup> Niclosamide exerts its anticestodal effect by inhibiting oxidative phosphorylation and stimulating adenosine triphosphatase activity in the mitochondria.
 <sup>
  <xref ref-type="bibr" rid="ref12">12</xref>
 </sup> Over the past several years, niclosamide has been identified as a multifunctional drug via drug repurposing screens. It can regulate multiple signaling pathways and biological processes including Wnt/β-catenin, mTORC1, STAT3, NF-κB, Notch, NS2B-NS3 interaction, and pH,
 <sup>
  <xref ref-type="bibr" rid="ref13">13</xref>,
  <xref ref-type="bibr" rid="ref14">14</xref>
 </sup> indicating its potential to treat other human conditions
 <sup>
  <xref ref-type="bibr" rid="ref15">15</xref>
 </sup> such as cancer,
 <sup>
  <xref ref-type="bibr" rid="ref16">16</xref>−
  <xref ref-type="bibr" rid="ref18">18</xref>
 </sup> bacterial and viral infections,
 <sup>
  <xref ref-type="bibr" rid="ref19">19</xref>−
  <xref ref-type="bibr" rid="ref22">22</xref>
 </sup> and metabolic diseases.
 <sup>
  <xref ref-type="bibr" rid="ref23">23</xref>
 </sup> These broad biological activities of niclosamide including relevant cell signaling pathways were briefly reviewed by Chen et al.
 <sup>
  <xref ref-type="bibr" rid="ref15">15</xref>
 </sup> In this short review, we focus on summarizing the broad antiviral activities of niclosamide (
 <xref rid="fig1" ref-type="fig">Figure 
  <xref rid="fig1" ref-type="fig">1</xref>
 </xref>) and highlighting its therapeutic potential in combating COVID-19.
</p>
